PharmaCorp Rx Inc.
PCRX.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.17M | -1.08M | 114.10K | -289.60K | -438.50K |
| Total Depreciation and Amortization | 796.30K | 673.50K | 565.10K | 459.30K | 339.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 363.20K | 313.50K | -296.90K | 98.30K | 108.30K |
| Change in Net Operating Assets | -556.20K | 1.54M | 768.50K | 12.00K | 290.90K |
| Cash from Operations | -569.60K | 1.44M | 1.15M | 280.10K | 300.10K |
| Capital Expenditure | -98.40K | -55.70K | -41.80K | -1.55M | -23.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -9.14M | -9.14M | -18.79M | -12.88M | -12.08M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -743.60K | -730.90K | -- | -- | -- |
| Cash from Investing | -9.98M | -9.93M | -18.83M | -14.43M | -12.10M |
| Total Debt Issued | 3.16M | 3.16M | -- | -- | -- |
| Total Debt Repaid | -378.80K | -323.00K | -213.30K | -193.00K | -157.80K |
| Issuance of Common Stock | 21.44M | 21.44M | 3.16M | 7.64M | 27.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 806.30K | 431.80K | -18.20K | -- | -- |
| Cash from Financing | 17.98M | 17.75M | 2.13M | 5.46M | 20.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.43M | 9.26M | -15.55M | -8.69M | 8.19M |